Galmed Pharmaceuticals Capital Expenditures (CapEx) Growth & History (GLMD)

Galmed Pharmaceuticals's capital expenditures (capex) was $4,000 for fiscal 2022.

View full Galmed Pharmaceuticals company overview

Galmed Pharmaceuticals annual capital expenditures (capex) history

Galmed Pharmaceuticals annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20222022-12-31$4,000−$7,000−63.64%
20212021-12-31$11,000−$33,000−75.00%
20202020-12-31$44,000$32,000+266.67%
20192019-12-31$12,000−$78,000−86.67%
20182018-12-31$90,000$78,000+650.00%
20172017-12-31$12,000−$5,000−29.41%
20162016-12-31$17,000−$142,000−89.31%
20152015-12-31$159,000−$611,000−79.35%
20142014-12-31$770,000$757,000+5823.08%
20132013-12-31$13,000−$19,000−59.38%
20122012-12-31$32,000

Galmed Pharmaceuticals capital expenditures (capex) trends

Over the last five fiscal years, Galmed Pharmaceuticals's capital expenditures (capex) decreased from $12,000 to $4,000, a change of −$8,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Galmed Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about GLMD yet. Start the conversation.

Write the first post